Trial Profile
PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Aug 2018
Price :
$35
*
At a glance
- Drugs Cinacalcet (Primary)
- Indications Primary hyperparathyroidism
- Focus Therapeutic Use
- Acronyms PRIMARA
- Sponsors Amgen
- 30 May 2014 New trial record
- 19 Oct 2012
- 24 Mar 2011